Details of the Drug

General Information of Drug (ID: DM9BM9L)

Drug Name

BAY-86-9596

Synonyms

D-FMT; D-18F-fluoromethyl tyrosine; D-fluoromethyl tyrosine-[18F]; Diagnostic 18F-labeled PET tracer, Bayer; 18-F PET tracer (diagnostic imaging), Bayer; 18F-labeled PET imaging agent (cancer), Bayer Schering Pharma

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C10H12FNO3
Canonical SMILES: C1=CC(=CC=C1CC(C(=O)O)N)OCF
InChI: 1S/C10H12FNO3/c11-6-15-8-3-1-7(2-4-8)5-9(12)10(13)14/h1-4,9H,5-6,12H2,(H,13,14)/t9-/m1/s1/i11-1
InChIKey: GEBHVOHKNWLITQ-DEVVULMSSA-N

Cross-matching ID

PubChem CID: 11579379
CAS Number: 870452-26-9
UNII: 58HVN5SR99
DrugBank ID: DB15296
TTD ID: D04KVQ

References

1	ClinicalTrials.gov (NCT01089998) PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations. U.S. National Institutes of Health.